Plasma exosome-derived connexin43 as a promising biomarker for melanoma patients

BACKGROUND: To examine the levels of exosome-derived connexin 43 (Cx43) in plasma and estimate its forecast value in patients with melanoma. METHODS: We measured the plasma exosome-derived Cx43 levels in the plasma of 112 melanoma patients and 50 healthy controls. RESULTS: The plasma exosome-derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yue, Li, Ming, Liao, Li, Gao, Suyue, Wang, Yongzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012581/
https://www.ncbi.nlm.nih.gov/pubmed/36918803
http://dx.doi.org/10.1186/s12885-023-10705-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012581/
https://www.ncbi.nlm.nih.gov/pubmed/36918803
http://dx.doi.org/10.1186/s12885-023-10705-9

Ejemplares similares